This study indicates that SON is overexpressed and plays a critical role in the proliferation, survival, and tumorigenicity of pancreatic cancer cells, suggesting that SON is a novel therapeutic molecular target for pancreatic cancer. This evidence concerns the gene SON and pancreatic neoplasm.